- 6 ماه پیش
- 296
- 06:28
ACC.24 Congress Coverage: REDUCE-IT trial
Daily cardiology
0
توضیحات
ACC.24: REDUCE-IT trial - Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl
Avatar
کاربر شنوتواولین نفر کامنت بزار
ACC.24: VICTORION-INITIATE trial - An “Inclisiran First” Strategy vs Usual Care in Patients With Atherosclerotic Cardiovascular Disease...
ACC.24: VICTORION-INITIATE trial - An “Inclisi...
05:15
- 296
- 6 ماه پیش
05:15
- 357
- 6 ماه پیش
ACC.24: BE ACTIVE Trial - Effect of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients at High Risk of Cardiovascular Events...
ACC.24: BE ACTIVE Trial - Effect of Gamificati...
04:13
- 357
- 6 ماه پیش
04:13
- 350
- 6 ماه پیش
ACC.24: TACTiC Trial...
ACC.24: TACTiC Trial
07:00
- 350
- 6 ماه پیش
07:00
- 315
- 6 ماه پیش
Infarction ACC.24: AEGIS-II Trial...
Infarction ACC.24: AEGIS-II Trial
05:15
- 315
- 6 ماه پیش
05:15
ACC.24 Congress Coverage: Trial of a Selective Aldose Reductase Inhibitor in Diabetic Cardiomyopathy
- 301
- 6 ماه پیش
ACC.24: ARISE-HF Trial...
ACC.24: ARISE-HF Trial
02:49
- 301
- 6 ماه پیش
02:49
ACC.24: SGLT2i in ACHD...
ACC.24: SGLT2i in ACHD
06:37
- 301
- 6 ماه پیش
06:37
ACC.24 Congress Coverage: Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk
- 366
- 6 ماه پیش
ACC.24: Bridge TIMI 73a Trial...
ACC.24: Bridge TIMI 73a Trial
05:32
- 366
- 6 ماه پیش
05:32
ACC.24: TACT 2 Trial...
ACC.24: TACT 2 Trial
02:57
- 366
- 6 ماه پیش
02:57
- 405
- 6 ماه پیش
ACC.24: Semaglutide in HFpEF and DM...
ACC.24: Semaglutide in HFpEF and DM
04:44
- 405
- 6 ماه پیش
04:44
تمامی حقوق این وبسایت متعلق به شنوتو است